Disease progression in patients with mild-to-moderate Alzheimer's disease treated with galantamine: Results of a two-year open-label study
2012
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI